Search company, investor...

Compare Mimetogen Pharmaceuticals vs Theraclone Sciences

Customers evaluate the quality of Mimetogen Pharmaceuticals's products using the following success metrics.

Overview

Mimetogen Pharmaceuticals is based in Canada

Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. The company designs and develops small molecule drugs that mimic the effects of neurotrophins, proteins that help maintain the health and growth of many cells and tissues found in the eye. Making drugs that can mimic the large natural molecules may lead to the development of novel approaches to treat degenerative ocular diseases such as glaucoma, retinitis pigmentosa, age-related macular degeneration and dry eye.

Theraclone Sciences is based in United States

Theraclone Sciences, formerly Spaltudaq, is a biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The companys technology harnesses the power of the human immune system to identify rare, naturally evolved antibodies from the blood cells of immunologically relevant human subjects. Human monoclonal antibodies can be rapidly isolated using the ISTAR discovery platform and scaled for industrial production. Such human antibody drug candidates may be uniquely safe and relevant to combating disease across broad patient populations.

Demo Video

Demo not available because Mimetogen Pharmaceuticals has not claimed their profile.

Work for Mimetogen Pharmaceuticals? Show off your product.

Demo not available because Theraclone Sciences has not claimed their profile.

Work for Theraclone Sciences? Show off your product.

Leadership

Martin B. Wax (Chief Executive Officer)

See all 5 people

David J Fanning (Chief Executive Officer, President)

See all 5 people

Funding

Mimetogen Pharmaceuticals last raised $800K on 7/19/2013.
Theraclone Sciences last raised $3.08M on 5/7/2015.

Investors

Medwell Capital, Inovia Capital

See all 3 investors

Canaan Partners, ARCH Venture Partners

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Mimetogen Pharmaceuticals has not claimed their profile.

Work for Mimetogen Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Mimetogen Pharmaceuticals?

Claim your profile now.

Information not available because Theraclone Sciences has not claimed their profile.

Work for Theraclone Sciences? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Theraclone Sciences?

Claim your profile now.